ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 0450 • ACR Convergence 2024

    Knowledge, Attitudes, and Intention Towards HPV Vaccination Among Reproductive-Age Women with Rheumatic Diseases

    Galilea Rodriguez1, Ana Rodriguez-Flores2, Mara Ponce3, Anahí Carrazco Chapa4, Karen Aglae Chavez-Olivo1, Aldo Patricio Romero-Avila1, Jesus Cardenas-de la Garza3, CASSANDRA SKINNER TAYLOR5, Lorena Perez-Barbosa6 and Dionicio Galarza-Delgado7, 1Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Mexico, 2Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, UANL, Rheumatology, Monterrey, Mexico, Monterrey, Mexico, 5HOSPITAL UNIVERSITARIO DR JOSE ELEUTERIO GONZALEZ, MONTERREY, Mexico, 6Hospital Universitario, UANL, Monterrey, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Women with autoimmune rheumatic disease (ARDs) have a higher risk for cervical cancer due to the persistence of the HPV infection. HPV vaccination is…
  • Abstract Number: 0458 • ACR Convergence 2024

    Long-Term Outcomes in Seronegative Rheumatoid Arthritis

    Bradly Kimbrough1, Cynthia Crowson2, Sara Achenbach3 and Elena Myasoedova2, 1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Rochester, Rochester, MN

    Background/Purpose: Seronegative rheumatoid arthritis (RA) is a heterogenous disease distinct from seropositive RA regarding genetic risk factors, pathobiology, and prognosis. Notably, recent studies have shown…
  • Abstract Number: 0384 • ACR Convergence 2024

    Pharmacokinetics of Ustekinumab in Patients with Juvenile Psoriatic Arthritis in a Real‑World Opportunistic Study

    Corey J. Bishop1, Edwin Lam2, Sophia G. Liva3, Jocelyn H. Leu2, Amy S. Paller4, Lucia Z. Diaz5, Laura Wine Lee6, Cory Rubin7, Ruy Carrasco8, Lisa Imundo9, Azadeh Majlessi10, Katherine Berezny1, Kathleen G. Lomax1, Valerie Smith1, Renping Zhang1 and hermine brunner11, 1Janssen Research & Development, Spring House, PA, 2Janssen Research & Development, LLC, a Johnson & Johnson company, Spring House, PA, PA, 3Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, PA, 4Northwestern University, Feinberg School of Medicine, Chicago, IL, 5Dell Children’s Medical Center; Dell Medical School at the University of Texas at Austin, Austin, TX, 6Medical University of South Carolina, Charleston, SC, 7Michigan Dermatology Institute, Waterford, MI, 8Pediatric Rheumatology Consultants of Austin, Austin, TX, 9Columbia University Medical Center, New York, NY, 10Newport Huntington Medical Group, Huntington Beach, CA, 11Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH

    Background/Purpose: Ustekinumab (UST), an interleukin‑12/23p40 antagonist, is currently approved for juvenile psoriatic arthritis (jPsA) solely in the United States (US). Although a phase 3 study…
  • Abstract Number: 0418 • ACR Convergence 2024

    Improving Documentation of Contraception and Pregnancy Intention in Rheumatology Practice

    Megan Clowse1, Puneet Bajaj2, Bonnie Bermas2, Julie Chiesa3, Kathryn Dao4, Pamela Freeman5, Bansari Gujar6, Brittany Hill7, Kelley Jones8, Richard Jones9, Ann Marslett10, Brooke Mills11, James Roberts2, Amanda Snyderman8 and Leah Zulig12, 1Duke University, Chapel Hill, NC, 2UT Southwestern Medical Center, Dallas, TX, 3InfoDirectors, Durham, NC, 4Rheum101, Rockville, MD, 5Rheumatology Associates of Central Florida, Orlando, FL, 6Rheumatology Associates of Baltimore, Towson, MD, 7Clinic for Rheumatic Disease, Tuscaloosa, AL, 8Duke University School of Medicine, Durham, 9Clinic for Rheumatic Diseases, Northport, AL, 10Rheumatology Associates of Baltimore, Baltimore, MD, 11UT Southwestern Medical Center, Fort Worth, TX, 12Duke University School of Medicine, Durham, NC

    Background/Purpose: Prior studies of RISE Registry found 9-11% of women of reproductive age with contraception documentation.  We sought to identify and assess methods to increase contraception documentation…
  • Abstract Number: 0380 • ACR Convergence 2024

    Joint Acoustic Emissions as a Digital Biomarker for Knee Inflammation in Juvenile Idiopathic Arthritis: A Pilot Study Using Musculoskeletal Ultrasound as Ground Truth

    Quentin Goossens1, Christopher Nichols1, Diana Sofia Villacis-Nunez2, Lori Ponder3, Omer Inan4 and Sampath Prahalad5, 1Georgia Institute of Technology, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Children's Healthcare of Atlanta, Atlanta, GA, 4Georgia Institute of Technology, Marietta, GA, 5Emory + Children's Pediatric Institute, Atlanta, GA

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic childhood arthropathy affecting 1 in 1000 children under 16, classified into seven categories by ILAR. Commonly, JIA…
  • Abstract Number: 0462 • ACR Convergence 2024

    Circulating Mediators of Endothelial Dysfunction as Predictors of Incident Heart Failure in Rheumatoid Arthritis

    Tate Johnson1, Michael Duryee1, Carlos Hunter1, Punyasha Roul2, Joshua Baker3, grant Cannon4, Beth Wallace5, Paul Monach6, Andreas Reimold7, Gail Kerr8, Isaac Smith9, John Richards10, Katherine Wysham11, Gary Kunkel12, Iris Lee13, Daniel Anderson14, Geoffrey Thiele1, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2UNMC, Omaha, NE, 3University of Pennsylvania, Philadelphia, PA, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 6VA Boston Healthcare System, Boston, MA, 7Dallas VA Medical Center, Dallas, TX, 8Washington DC VAMC/Georgetown and Howard Universities, Washington, DC, 9Duke University Hospital, Durham, NC, 10Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 11VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA, 12University of Utah and George E Wahlen VAMC, Salt Lake City, UT, 13Washington University in St Louis, Saint Louis, MO, 14University of Nebraska Medical Center, Durham, NC

    Background/Purpose: Endothelial dysfunction, leading to myocardial inflammation and dysfunction, may drive a heightened risk of heart failure (HF) in people with rheumatoid arthritis (RA). Circulating…
  • Abstract Number: 0253 • ACR Convergence 2024

    Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Diseases

    Justine Enns1, Shruthi Srivatsan1, Bohang Jiang1, Miao Lin1, Emily Kowalski2, Naomi Patel1, Xiaosong Wang3, Zachary Williams1, Grace Qian3, Jennifer Hanberg1, Colebrook Johnson1, Madison Negron1, Katarina Bade2, Alene Saavedra2, Kevin Mueller2, Kathleen Vanni3, Jeffrey Sparks4 and Zachary Wallace5, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, 5Massachusetts General Hospital, Newton, MA

    Background/Purpose: Respiratory Syncytial Virus (RSV) can cause a severe respiratory illness, especially in older adults and those with significant comorbidities. In June 2023 the US…
  • Abstract Number: 0449 • ACR Convergence 2024

    Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects

    Ana Cecilia Bardan-Inchaustegui1, Iris Jazmín Colunga Pedraza2, Rosa Icela Arvizu-Rivera2, Gisela Garcia-Arellano3, Griselda Serna-Peña4, Maria F. Elizondo-Benitez5, Aleydis Gonzalez Melendez2, Fernanda Massiel Garcia6 and Dionicio Galarza-Delgado7, 1Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Hospital Universitario \"Dr. José Eleuterio González\", Monterrey, Nuevo León, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome, is classified as a psychiatric disorder characterized by moderate to severe physical, affective, or…
  • Abstract Number: 0426 • ACR Convergence 2024

    Quality Improvement Initiative to Increase Contraception Screening and Documentation for Reproductive-Aged Women Prescribed Teratogenic Medications in an Academic Rheumatology Center

    Caroline Siegel1, Avi Mikhaylov1, Emily Wu2, Deanna Jannat-Khah1, Erika Abramson3, Lisa Sammaritano4 and Nancy Pan5, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Rochester, NY, 3Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery, Scarsdale, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Rheumatology patients prescribed teratogenic medications often are not prescribed effective contraception. Efforts to improve this important quality indicator are limited by inadequate and poorly…
  • Abstract Number: 0211 • ACR Convergence 2024

    Characteristics of Hospitalizations and Outpatient Follow-up for Patients with SLE at an Academic Hospital Setting in Austin, Texas

    Riti Kotamarti1 and Veena Patel2, 1Dell Seton Medical Center, Austin, TX, 2Dell Medical School - UT Health Austin, Austin, TX

    Background/Purpose: Patients with SLE have high rates of hospitalizations annually and require careful coordination of care in both the inpatient and outpatient setting. Prior analyses…
  • Abstract Number: 0363 • ACR Convergence 2024

    Comparative Risk of Demyelinating Diseases Among Patients on TNF-Alpha Inhibitors: A Cohort Study Using the TriNetX Database

    Rafal Ali1, Yurilu Gonzalez Moret2, Roua Hussein3 and Fabian Rodriguez4, 1Jefferson Einstein Philadelphia, Lansdale, PA, 2Jefferson Einstein Philadelphia, Philadelphia, PA, 3Al-Mustansiriyah University/ college of medicine, New York, NY, 4Jefferson Einstein Hospital, Philadelphia, PA

    Background/Purpose: TNF-alpha inhibitors are widely used in the field of rheumatology and have been linked to various possible adverse events, including demyelinating diseases. This association…
  • Abstract Number: 0471 • ACR Convergence 2024

    Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients with Rheumatoid Arthritis

    Jose Viotti-Serra1, Maria Garcia-Gonzalez2, Fuensanta Gomez-Bernal1, Juan Carlos Quevedo-Abeledo3, Miguel Angel Gonzalez-Gay4 and ivan Ferraz-Amaro5, 1Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 2Hospital Universitario de Canarias, SC Tenerife, Canarias, Spain, 3Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de GC, Canarias, Spain, 4University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 5Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain

    Background/Purpose: The complement (C) system has been associated with the etiopathogenesis of rheumatoid arthritis (RA). Insulin resistance (IR) and metabolic syndrome are prevalent among RA…
  • Abstract Number: 0215 • ACR Convergence 2024

    BP Connect Improves Follow-up of High Blood Pressure in Urban Rheumatology and Non-Rheumatology Clinics

    Alexa Figueroa Baiges1, David Gazeley2, Monica Messina1, Bret Hanlon3, Edmond Ramly4, Ann Rosenthal5, Laura Stewart6, Makeba Williams7, Heidi W. Brown8 and Christie Bartels9, 1Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Medical College of Wisconsin, Wauwatosa, WI, 3Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Indiana University School of Public Health, Bloomington, IN, 5Medical College of Wisconsin, Milwaukee, WI, 6Froedtert and Medical College of Wisconsin, Milwaukee, WI, 7Washington University in St. Louis School of Medicine, St. Louis, MO, 8Division of Health Services Research & Implementation Science, Kaiser Permanente, San Diego, CA, 9University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hypertension accounts for >54% of modifiable cardiovascular disease (CVD) risk and although 49% of US outpatient visits occur in specialty clinics, only 10% of…
  • Abstract Number: 0229 • ACR Convergence 2024

    An Early Inflammatory Cardiac Phenotype and Association with Future Coronary Plaque Burden in Rheumatoid Arthritis

    Brittany Weber1, Feng Liu2, Mary Jeffway2, Dana Weisenfeld2, Gregory McDermott3, Elena Massarotti2, Jonathan Coblyn2, Michael Weinblatt4, Marcelo Di Carli2, Damini Dey5 and Katherine Liao2, 1Brigham and Women's Hospital, DEDHAM, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women's Hospital, Brookline, MA, 4Brigham and Women's Hospital/ Harvard Medical School, Waban, MA, 5Cedars-Sinai Medical Center, Los Angeles

    Background/Purpose: Patients with RA are at increased risk of cardiovascular disease (CVD) compared to the general population.  In a prior study of RA patients with…
  • Abstract Number: 0387 • ACR Convergence 2024

    Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists

    Farzana Nuruzzaman1, T. Shawn Sato2, Jennifer Stimec3, Ramesh S. Iyer4, Andrew Carbert5, Joel Paschke5, Lauren Potts6, Xiaoyue Zhang7, Walter Maksymowych8, Polly Ferguson9 and Yongdong (Dan) Zhao10, and CARRA CRMO Workgroup, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, 3Hospital for Sick Children, Toronto, ON, Canada, 4Seattle Children's Hospital, Seattle, WA, 5CARE Arthritis, Edmonton, AB, Canada, 6Artist, Long Beach, CA, 7Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 8University of Alberta, Edmonton, AB, Canada, 9University of Iowa Carver College of Medicine, Iowa City, IA, 10University of Washington, Redmond, WA

    Background/Purpose: The web-based ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) portal was developed to assess specific features of bone and soft tissue inflammation in…
  • « Previous Page
  • 1
  • …
  • 344
  • 345
  • 346
  • 347
  • 348
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology